Market News

Breaking headlines and analysis across every asset class.

Markets
Investing.com Canada • Sep 28, 2026
Eton Pharmaceuticals launches IMPAVIDO for leishmaniasis By Investing.com

Eton Pharmaceuticals (NASDAQ:ETON) has launched IMPAVIDO (miltefosine) capsules in the United States, for which it now holds exclusive commercialization rights. The drug is indicated for the treatment of various forms of leishmaniasis in adults and adolescents aged 12 and older weighing at least 30 kg. Eton has implemented a patient support program, Eton Cares, and centralized distribution through Anovo Specialty Pharmacy.

Markets
AD HOC NEWS • Sep 28, 2026
Fifth Third stock rises 1.24 percent as dividend grows

Fifth Third Bancorp's stock increased by 1.24 percent, reaching USD 52.10 on the NYSE, following an announcement of a 5 percent increase in its quarterly common dividend to USD 0.42. The bank reported strong second-quarter earnings, with net income of USD 763.0 million and a 48 percent year-over-year gain in net interest income. Despite analysts lowering price targets, the dividend increase and solid financial performance contributed to investor confidence.

Markets
Fortune • Sep 28, 2026
The economist who coined the phrase 'Magnificent 7' says the very thing that made them extraordinary is under threat

Michael Hartnett, who coined the "Magnificent 7" phrase, warns that the very characteristic that made these tech giants extraordinary—their ability to generate significant cash without spending it—is now threatened. Due to massive AI investments, these companies are becoming increasingly reliant on the bond market, tying their prospects to an asset class they once hedged against. Hartnett suggests that policymakers might intervene to stabilize the bond market, as higher yields could hinder AI in

Markets
AD HOC NEWS • Sep 28, 2026
Caesars Entertainment stock trails USD 31.00 merger payout after vote

Caesars Entertainment shareholders have approved a merger with Fertitta Entertainment, which will provide a USD 31.00 cash payout per eligible share. Despite the approval, the stock closed at USD 29.59 on September 25, 2026, meaning it trades below the merger consideration. Regulatory review by the FTC is ongoing, extending the antitrust review period and making the closing timeline a key factor.

Markets
Investing.com Nigeria • Sep 28, 2026
NetEase shares climb in Hong Kong after Morgan Stanley Top Pick designation

NetEase Inc. shares rose in Hong Kong trading after Morgan Stanley named the company its top pick among industry peers. The brokerage firm anticipates NetEase's upcoming game, Ananta, to be a major success and a key growth driver in 2027. This upgrade comes as NetEase prepares for Ananta's release, which Morgan Stanley believes holds significant commercial potential.

Markets
GuruFocus • Sep 28, 2026
ETFs Bought $21.0 Million of NextEra Energy (NEE) on Thursday

On Thursday, ETFs bought a net of $21.0 million worth of NextEra Energy (NEE) shares, with 29 funds adding and 19 trimming positions. This marks the fifth consecutive day of net inflows for the utility company, following significant buying activity earlier in the week. The largest buyer was XLU, which increased its stake by 1.14%, contributing to the ongoing positive ETF activity for NEE.

Markets
Yahoo Finance • Sep 28, 2026
First Solar Shares Rise After KeyBanc Removes Underweight Rating

First Solar (NASDAQ:FSLR) shares rose in pre-market trading after KeyBanc upgraded the solar technology company to Sector Weight from Underweight. The upgrade was driven by valuation following a 32% year-to-date decline in the stock, bringing it closer to KeyBanc's previous price target. KeyBanc noted that the company's advanced manufacturing tax credits and cash contribute approximately $135 per share to its valuation.

Markets
AD HOC NEWS • Sep 28, 2026
Merck & Co. stock trades at USD 148.74 after pipeline updates

Merck & Co. stock was trading at USD 148.74 on September 25, 2026, driven by recent pipeline updates, including FDA approval for WELIREG plus LENVIMA and positive results from the BRUNELLO study. The company reported strong Q2 2026 worldwide sales of USD 16.6 billion, exceeding consensus estimates. Analysts, like Guggenheim, have raised target prices to USD 170 with a Buy rating, despite potential future competition for Keytruda.

Markets
Stock Titan • Sep 28, 2026
BlackRock's voting rights fall below 7% at Caledonia Mining (CMCL)

BlackRock, Inc. has notified Caledonia Mining Corporation Plc that its voting rights in the company have decreased to 6.96%, falling below the 7% threshold. This change, reported on September 24, 2026, reflects a shift from its previous reported position of 7.04%. The 6.96% total voting rights comprise 5.03% attached to shares and 1.92% through financial instruments, including securities lending and cash-settled CFDs.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.